We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
American Eagle Outfitters
AEO
$2.86B
| $5.11K | ﹤0.01% |
297
+184
| +163% | +$3.19K |
|
2427
RH
RH
$3.14B
| $5.11K | ﹤0.01% |
31
-5
| -14% | -$689 |
|
2428
Enerpac Tool Group
EPAC
$1.76B
| $5.06K | ﹤0.01% |
141
+34
| +32% | +$1.19K |
|
2429
Grocery Outlet
GO
$884M
| $5.04K | ﹤0.01% |
+505
| New | +$4.16K |
|
2430
Phillips Edison & Co
PECO
$5.38B
| $5.04K | ﹤0.01% |
121
| – | – |
|
2431
Artesian Resources
ARTNA
$350M
| $5.03K | ﹤0.01% |
148
| – | – |
|
2432
VSE Corp
VSEC
$5.54B
| $5.03K | ﹤0.01% |
22
+1
| +5% | +$192 |
|
|
SOBO
2433
South Bow Corp
SOBO
$8.07B
| $4.97K | ﹤0.01% |
141
| – | – |
|
2434
Tandem Diabetes Care
TNDM
$1.16B
| $4.95K | ﹤0.01% |
328
-3,007
| -90% | -$52.5K |
|
2435
Dr. Reddy's Laboratories
RDY
$9.83B
| $4.93K | ﹤0.01% |
340
+113
| +50% | +$1.52K |
|
2436
Edgewise Therapeutics
EWTX
$4.23B
| $4.88K | ﹤0.01% |
120
+25
| +26% | +$862 |
|
|
FPI
2437
Farmland Partners
FPI
$417M
| $4.87K | ﹤0.01% |
503
+103
| +26% | +$1.1K |
|
2438
St. Joe Company
JOE
$3.57B
| $4.82K | ﹤0.01% |
77
| – | – |
|
2439
Crinetics Pharmaceuticals
CRNX
$8.85B
| $4.79K | ﹤0.01% |
128
+9
| +8% | +$335 |
|
2440
Tradeweb Markets
TW
$21.3B
| $4.78K | ﹤0.01% |
48
-35
| -42% | -$3.8K |
|
2441
International Money Express
IMXI
$401M
| $4.78K | ﹤0.01% |
331
-1,513
| -82% | -$23.2K |
|
2442
American Airlines Group
AAL
$8.97B
| $4.77K | ﹤0.01% |
264
-52
| -16% | -$696 |
|
|
LGN
2443
Legence Corp
LGN
$5.76B
| $4.69K | ﹤0.01% |
55
| – | – |
|
2444
American Coastal Insurance
ACIC
$484M
| $4.64K | ﹤0.01% |
418
+266
| +175% | +$2.94K |
|
2445
Blue Owl Capital
OWL
$6.22B
| $4.59K | ﹤0.01% |
525
| – | – |
|
2446
i3 Verticals
IIIV
$387M
| $4.59K | ﹤0.01% |
215
-496
| -70% | -$10.3K |
|
2447
Digi International
DGII
$2.48B
| $4.57K | ﹤0.01% |
61
| – | – |
|
2448
Leonardo DRS
DRS
$12.8B
| $4.57K | ﹤0.01% |
107
| – | – |
|
2449
LendingTree
TREE
$550M
| $4.47K | ﹤0.01% |
101
-574
| -85% | -$23.2K |
|
2450
EverCommerce
EVCM
$1.96B
| $4.47K | ﹤0.01% |
444
-137
| -24% | -$1.45K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.